経肺ドラッグデリバリーシステムのグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Pulmonary Drug Delivery Systems Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B15344 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療装置

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

経肺ドラッグデリバリーシステム市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の経肺ドラッグデリバリーシステムの市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界の経肺ドラッグデリバリーシステムの市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 経肺ドラッグデリバリーシステム市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・ネブライザー、ドライパウダー吸入器（DPI）、定量吸入器（MDI） 用途別セグメントは次のように区分されます。 ・COPD、喘息、その他 世界の経肺ドラッグデリバリーシステム市場の主要な市場プレーヤーは以下のとおりです。 ・3M、GSK、AstraZeneca、Cipla、Chiesi、Boehringer Ingelheim、Aptar、Novartis、Philips Respironics、Omron Healthcare、PARI、Skyepharma、CareFusion、Shanghai Huarui、Taian Character、Chia Tai Tianqing 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、経肺ドラッグデリバリーシステム製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な経肺ドラッグデリバリーシステムメーカーの企業概要、2019年～2021年までの経肺ドラッグデリバリーシステムの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な経肺ドラッグデリバリーシステムメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別経肺ドラッグデリバリーシステムの販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までの経肺ドラッグデリバリーシステムの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域での経肺ドラッグデリバリーシステム市場予測を収録しています。 ・第12、13、14章では、経肺ドラッグデリバリーシステムの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：3M、GSK、AstraZeneca、Cipla、Chiesi、Boehringer Ingelheim、Aptar、Novartis、Philips Respironics、Omron Healthcare、PARI、Skyepharma、CareFusion、Shanghai Huarui、Taian Character、Chia Tai Tianqing ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ネブライザー、ドライパウダー吸入器（DPI）、定量吸入器（MDI） ・用途別分析2016年-2026年：COPD、喘息、その他 ・経肺ドラッグデリバリーシステムの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・経肺ドラッグデリバリーシステムのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・経肺ドラッグデリバリーシステムのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・経肺ドラッグデリバリーシステムの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・経肺ドラッグデリバリーシステムの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Pulmonary Drug Delivery Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Pulmonary Drug Delivery Systems size is estimated to be XX million in 2021 from USD 3007.9 million in 2020, with a change of XX% between 2020 and 2021. The global Pulmonary Drug Delivery Systems market size is expected to grow at a CAGR of 4.0% for the next five years.

Market segmentation
Pulmonary Drug Delivery Systems market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Nebulizers
Dry Powder Inhaler (DPI)
Metered Dose Inhaler (MDI)

Market segment by Application can be divided into
COPD
Asthma
Others

The key market players for global Pulmonary Drug Delivery Systems market are listed below:
3M
GSK
AstraZeneca
Cipla
Chiesi
Boehringer Ingelheim
Aptar
Novartis
Philips Respironics
Omron Healthcare
PARI
Skyepharma
CareFusion
Shanghai Huarui
Taian Character
Chia Tai Tianqing

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Pulmonary Drug Delivery Systems product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pulmonary Drug Delivery Systems, with price, sales, revenue and global market share of Pulmonary Drug Delivery Systems from 2019 to 2021.
Chapter 3, the Pulmonary Drug Delivery Systems competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pulmonary Drug Delivery Systems breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Pulmonary Drug Delivery Systems market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Pulmonary Drug Delivery Systems sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Pulmonary Drug Delivery Systems Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pulmonary Drug Delivery Systems Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Nebulizers
1.2.3 Dry Powder Inhaler (DPI)
1.2.4 Metered Dose Inhaler (MDI)
1.3 Market Analysis by Application
1.3.1 Overview: Global Pulmonary Drug Delivery Systems Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 COPD
1.3.3 Asthma
1.3.4 Others
1.4 Global Pulmonary Drug Delivery Systems Market Size & Forecast
1.4.1 Global Pulmonary Drug Delivery Systems Sales in Value (2016-2026))
1.4.2 Global Pulmonary Drug Delivery Systems Sales in Volume (2016-2026)
1.4.3 Global Pulmonary Drug Delivery Systems Price by Type (2016-2026) & (US$/Unit)
1.5 Global Pulmonary Drug Delivery Systems Production Capacity Analysis
1.5.1 Global Pulmonary Drug Delivery Systems Total Production Capacity (2016-2026)
1.5.2 Global Pulmonary Drug Delivery Systems Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pulmonary Drug Delivery Systems Market Drivers
1.6.2 Pulmonary Drug Delivery Systems Market Restraints
1.6.3 Pulmonary Drug Delivery Systems Trends Analysis
2 Manufacturers Profiles
2.1 3M
2.1.1 3M Details
2.1.2 3M Major Business
2.1.3 3M Pulmonary Drug Delivery Systems Product and Services
2.1.4 3M Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Pulmonary Drug Delivery Systems Product and Services
2.2.4 GSK Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Pulmonary Drug Delivery Systems Product and Services
2.3.4 AstraZeneca Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Cipla
2.4.1 Cipla Details
2.4.2 Cipla Major Business
2.4.3 Cipla Pulmonary Drug Delivery Systems Product and Services
2.4.4 Cipla Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Chiesi
2.5.1 Chiesi Details
2.5.2 Chiesi Major Business
2.5.3 Chiesi Pulmonary Drug Delivery Systems Product and Services
2.5.4 Chiesi Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business
2.6.3 Boehringer Ingelheim Pulmonary Drug Delivery Systems Product and Services
2.6.4 Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Aptar
2.7.1 Aptar Details
2.7.2 Aptar Major Business
2.7.3 Aptar Pulmonary Drug Delivery Systems Product and Services
2.7.4 Aptar Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Pulmonary Drug Delivery Systems Product and Services
2.8.4 Novartis Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Philips Respironics
2.9.1 Philips Respironics Details
2.9.2 Philips Respironics Major Business
2.9.3 Philips Respironics Pulmonary Drug Delivery Systems Product and Services
2.9.4 Philips Respironics Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Omron Healthcare
2.10.1 Omron Healthcare Details
2.10.2 Omron Healthcare Major Business
2.10.3 Omron Healthcare Pulmonary Drug Delivery Systems Product and Services
2.10.4 Omron Healthcare Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 PARI
2.11.1 PARI Details
2.11.2 PARI Major Business
2.11.3 PARI Pulmonary Drug Delivery Systems Product and Services
2.11.4 PARI Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Skyepharma
2.12.1 Skyepharma Details
2.12.2 Skyepharma Major Business
2.12.3 Skyepharma Pulmonary Drug Delivery Systems Product and Services
2.12.4 Skyepharma Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 CareFusion
2.13.1 CareFusion Details
2.13.2 CareFusion Major Business
2.13.3 CareFusion Pulmonary Drug Delivery Systems Product and Services
2.13.4 CareFusion Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Shanghai Huarui
2.14.1 Shanghai Huarui Details
2.14.2 Shanghai Huarui Major Business
2.14.3 Shanghai Huarui Pulmonary Drug Delivery Systems Product and Services
2.14.4 Shanghai Huarui Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Taian Character
2.15.1 Taian Character Details
2.15.2 Taian Character Major Business
2.15.3 Taian Character Pulmonary Drug Delivery Systems Product and Services
2.15.4 Taian Character Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Chia Tai Tianqing
2.16.1 Chia Tai Tianqing Details
2.16.2 Chia Tai Tianqing Major Business
2.16.3 Chia Tai Tianqing Pulmonary Drug Delivery Systems Product and Services
2.16.4 Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Pulmonary Drug Delivery Systems Sales by Manufacturer
3.1 Global Pulmonary Drug Delivery Systems Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Pulmonary Drug Delivery Systems Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Pulmonary Drug Delivery Systems
3.4 Market Concentration Rate
3.4.1 Top 3 Pulmonary Drug Delivery Systems Manufacturer Market Share
3.4.2 Top 6 Pulmonary Drug Delivery Systems Manufacturer Market Share
3.5 Global Pulmonary Drug Delivery Systems Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Pulmonary Drug Delivery Systems Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pulmonary Drug Delivery Systems Market Size by Region
4.1.1 Global Pulmonary Drug Delivery Systems Sales in Volume by Region (2016-2026)
4.1.2 Global Pulmonary Drug Delivery Systems Revenue by Region (2016-2026)
4.2 North America Pulmonary Drug Delivery Systems Revenue (2016-2026)
4.3 Europe Pulmonary Drug Delivery Systems Revenue (2016-2026)
4.4 Asia-Pacific Pulmonary Drug Delivery Systems Revenue (2016-2026)
4.5 South America Pulmonary Drug Delivery Systems Revenue (2016-2026)
4.6 Middle East and Africa Pulmonary Drug Delivery Systems Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Pulmonary Drug Delivery Systems Sales in Volume by Type (2016-2026)
5.2 Global Pulmonary Drug Delivery Systems Revenue by Type (2016-2026)
5.3 Global Pulmonary Drug Delivery Systems Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Pulmonary Drug Delivery Systems Sales in Volume by Application (2016-2026)
6.2 Global Pulmonary Drug Delivery Systems Revenue by Application (2016-2026)
6.3 Global Pulmonary Drug Delivery Systems Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Pulmonary Drug Delivery Systems Sales by Type (2016-2026)
7.2 North America Pulmonary Drug Delivery Systems Sales by Application (2016-2026)
7.3 North America Pulmonary Drug Delivery Systems Market Size by Country
7.3.1 North America Pulmonary Drug Delivery Systems Sales in Volume by Country (2016-2026)
7.3.2 North America Pulmonary Drug Delivery Systems Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Pulmonary Drug Delivery Systems Sales by Type (2016-2026)
8.2 Europe Pulmonary Drug Delivery Systems Sales by Application (2016-2026)
8.3 Europe Pulmonary Drug Delivery Systems Market Size by Country
8.3.1 Europe Pulmonary Drug Delivery Systems Sales in Volume by Country (2016-2026)
8.3.2 Europe Pulmonary Drug Delivery Systems Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Pulmonary Drug Delivery Systems Sales by Type (2016-2026)
9.2 Asia-Pacific Pulmonary Drug Delivery Systems Sales by Application (2016-2026)
9.3 Asia-Pacific Pulmonary Drug Delivery Systems Market Size by Region
9.3.1 Asia-Pacific Pulmonary Drug Delivery Systems Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Pulmonary Drug Delivery Systems Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Pulmonary Drug Delivery Systems Sales by Type (2016-2026)
10.2 South America Pulmonary Drug Delivery Systems Sales by Application (2016-2026)
10.3 South America Pulmonary Drug Delivery Systems Market Size by Country
10.3.1 South America Pulmonary Drug Delivery Systems Sales in Volume by Country (2016-2026)
10.3.2 South America Pulmonary Drug Delivery Systems Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pulmonary Drug Delivery Systems Sales by Type (2016-2026)
11.2 Middle East & Africa Pulmonary Drug Delivery Systems Sales by Application (2016-2026)
11.3 Middle East & Africa Pulmonary Drug Delivery Systems Market Size by Country
11.3.1 Middle East & Africa Pulmonary Drug Delivery Systems Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Pulmonary Drug Delivery Systems Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Pulmonary Drug Delivery Systems Typical Distributors
12.3 Pulmonary Drug Delivery Systems Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Pulmonary Drug Delivery Systems Revenue by Type, (USD Million), 2021-2026
Table 2. Global Pulmonary Drug Delivery Systems Revenue by Application, (USD Million), 2021-2026
Table 3. 3M Basic Information, Manufacturing Base and Competitors
Table 4. 3M Major Business
Table 5. 3M Pulmonary Drug Delivery Systems Product and Services
Table 6. 3M Pulmonary Drug Delivery Systems Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Pulmonary Drug Delivery Systems Product and Services
Table 10. GSK Pulmonary Drug Delivery Systems Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 12. AstraZeneca Major Business
Table 13. AstraZeneca Pulmonary Drug Delivery Systems Product and Services
Table 14. AstraZeneca Pulmonary Drug Delivery Systems Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Cipla Basic Information, Manufacturing Base and Competitors
Table 16. Cipla Major Business
Table 17. Cipla Pulmonary Drug Delivery Systems Product and Services
Table 18. Cipla Pulmonary Drug Delivery Systems Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Chiesi Basic Information, Manufacturing Base and Competitors
Table 20. Chiesi Major Business
Table 21. Chiesi Pulmonary Drug Delivery Systems Product and Services
Table 22. Chiesi Pulmonary Drug Delivery Systems Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 24. Boehringer Ingelheim Major Business
Table 25. Boehringer Ingelheim Pulmonary Drug Delivery Systems Product and Services
Table 26. Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Aptar Basic Information, Manufacturing Base and Competitors
Table 28. Aptar Major Business
Table 29. Aptar Pulmonary Drug Delivery Systems Product and Services
Table 30. Aptar Pulmonary Drug Delivery Systems Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Major Business
Table 33. Novartis Pulmonary Drug Delivery Systems Product and Services
Table 34. Novartis Pulmonary Drug Delivery Systems Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Philips Respironics Basic Information, Manufacturing Base and Competitors
Table 36. Philips Respironics Major Business
Table 37. Philips Respironics Pulmonary Drug Delivery Systems Product and Services
Table 38. Philips Respironics Pulmonary Drug Delivery Systems Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Omron Healthcare Basic Information, Manufacturing Base and Competitors
Table 40. Omron Healthcare Major Business
Table 41. Omron Healthcare Pulmonary Drug Delivery Systems Product and Services
Table 42. Omron Healthcare Pulmonary Drug Delivery Systems Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. PARI Basic Information, Manufacturing Base and Competitors
Table 44. PARI Major Business
Table 45. PARI Pulmonary Drug Delivery Systems Product and Services
Table 46. PARI Pulmonary Drug Delivery Systems Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Skyepharma Basic Information, Manufacturing Base and Competitors
Table 48. Skyepharma Major Business
Table 49. Skyepharma Pulmonary Drug Delivery Systems Product and Services
Table 50. Skyepharma Pulmonary Drug Delivery Systems Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. CareFusion Basic Information, Manufacturing Base and Competitors
Table 52. CareFusion Major Business
Table 53. CareFusion Pulmonary Drug Delivery Systems Product and Services
Table 54. CareFusion Pulmonary Drug Delivery Systems Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Shanghai Huarui Basic Information, Manufacturing Base and Competitors
Table 56. Shanghai Huarui Major Business
Table 57. Shanghai Huarui Pulmonary Drug Delivery Systems Product and Services
Table 58. Shanghai Huarui Pulmonary Drug Delivery Systems Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Taian Character Basic Information, Manufacturing Base and Competitors
Table 60. Taian Character Major Business
Table 61. Taian Character Pulmonary Drug Delivery Systems Product and Services
Table 62. Taian Character Pulmonary Drug Delivery Systems Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Chia Tai Tianqing Basic Information, Manufacturing Base and Competitors
Table 64. Chia Tai Tianqing Major Business
Table 65. Chia Tai Tianqing Pulmonary Drug Delivery Systems Product and Services
Table 66. Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Global Pulmonary Drug Delivery Systems Sales by Manufacturer (2019-2021e) & (M Units)
Table 68. Global Pulmonary Drug Delivery Systems Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 69. Market Position of Manufacturers in Pulmonary Drug Delivery Systems, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 70. Global Pulmonary Drug Delivery Systems Production Capacity by Company, (M Units): 2020 VS 2021
Table 71. Head Office and Pulmonary Drug Delivery Systems Production Site of Key Manufacturer
Table 72. Pulmonary Drug Delivery Systems New Entrant and Capacity Expansion Plans
Table 73. Pulmonary Drug Delivery Systems Mergers & Acquisitions in the Past Five Years
Table 74. Global Pulmonary Drug Delivery Systems Sales by Region (2016-2021e) & (M Units)
Table 75. Global Pulmonary Drug Delivery Systems Sales by Region (2021-2026) & (M Units)
Table 76. Global Pulmonary Drug Delivery Systems Revenue by Region (2016-2021e) & (USD Million)
Table 77. Global Pulmonary Drug Delivery Systems Revenue by Region (2021-2026) & (USD Million)
Table 78. Global Pulmonary Drug Delivery Systems Sales by Type (2016-2021e) & (M Units)
Table 79. Global Pulmonary Drug Delivery Systems Sales by Type (2021-2026) & (M Units)
Table 80. Global Pulmonary Drug Delivery Systems Revenue by Type (2016-2021e) & (USD Million)
Table 81. Global Pulmonary Drug Delivery Systems Revenue by Type (2021-2026) & (USD Million)
Table 82. Global Pulmonary Drug Delivery Systems Price by Type (2016-2021e) & (US$/Unit)
Table 83. Global Pulmonary Drug Delivery Systems Price by Type (2021-2026) & (US$/Unit)
Table 84. Global Pulmonary Drug Delivery Systems Sales by Application (2016-2021e) & (M Units)
Table 85. Global Pulmonary Drug Delivery Systems Sales by Application (2021-2026) & (M Units)
Table 86. Global Pulmonary Drug Delivery Systems Revenue by Application (2016-2021e) & (USD Million)
Table 87. Global Pulmonary Drug Delivery Systems Revenue by Application (2021-2026) & (USD Million)
Table 88. Global Pulmonary Drug Delivery Systems Price by Application (2016-2021e) & (US$/Unit)
Table 89. Global Pulmonary Drug Delivery Systems Price by Application (2021-2026) & (US$/Unit)
Table 90. North America Pulmonary Drug Delivery Systems Sales by Country (2016-2021e) & (M Units)
Table 91. North America Pulmonary Drug Delivery Systems Sales by Country (2021-2026) & (M Units)
Table 92. North America Pulmonary Drug Delivery Systems Revenue by Country (2016-2021e) & (USD Million)
Table 93. North America Pulmonary Drug Delivery Systems Revenue by Country (2021-2026) & (USD Million)
Table 94. North America Pulmonary Drug Delivery Systems Sales by Type (2016-2021e) & (M Units)
Table 95. North America Pulmonary Drug Delivery Systems Sales by Type (2021-2026) & (M Units)
Table 96. North America Pulmonary Drug Delivery Systems Sales by Application (2016-2021e) & (M Units)
Table 97. North America Pulmonary Drug Delivery Systems Sales by Application (2021-2026) & (M Units)
Table 98. Europe Pulmonary Drug Delivery Systems Sales by Country (2016-2021e) & (M Units)
Table 99. Europe Pulmonary Drug Delivery Systems Sales by Country (2021-2026) & (M Units)
Table 100. Europe Pulmonary Drug Delivery Systems Revenue by Country (2016-2021e) & (USD Million)
Table 101. Europe Pulmonary Drug Delivery Systems Revenue by Country (2021-2026) & (USD Million)
Table 102. Europe Pulmonary Drug Delivery Systems Sales by Type (2016-2021e) & (M Units)
Table 103. Europe Pulmonary Drug Delivery Systems Sales by Type (2021-2026) & (M Units)
Table 104. Europe Pulmonary Drug Delivery Systems Sales by Application (2016-2021e) & (M Units)
Table 105. Europe Pulmonary Drug Delivery Systems Sales by Application (2021-2026) & (M Units)
Table 106. Asia-Pacific Pulmonary Drug Delivery Systems Sales by Region (2016-2021e) & (M Units)
Table 107. Asia-Pacific Pulmonary Drug Delivery Systems Sales by Region (2021-2026) & (M Units)
Table 108. Asia-Pacific Pulmonary Drug Delivery Systems Revenue by Region (2016-2021e) & (USD Million)
Table 109. Asia-Pacific Pulmonary Drug Delivery Systems Revenue by Region (2021-2026) & (USD Million)
Table 110. Asia-Pacific Pulmonary Drug Delivery Systems Sales by Type (2016-2021e) & (M Units)
Table 111. Asia-Pacific Pulmonary Drug Delivery Systems Sales by Type (2021-2026) & (M Units)
Table 112. Asia-Pacific Pulmonary Drug Delivery Systems Sales by Application (2016-2021e) & (M Units)
Table 113. Asia-Pacific Pulmonary Drug Delivery Systems Sales by Application (2021-2026) & (M Units)
Table 114. South America Pulmonary Drug Delivery Systems Sales by Country (2016-2021e) & (M Units)
Table 115. South America Pulmonary Drug Delivery Systems Sales by Country (2021-2026) & (M Units)
Table 116. South America Pulmonary Drug Delivery Systems Revenue by Country (2016-2021e) & (USD Million)
Table 117. South America Pulmonary Drug Delivery Systems Revenue by Country (2021-2026) & (USD Million)
Table 118. South America Pulmonary Drug Delivery Systems Sales by Type (2016-2021e) & (M Units)
Table 119. South America Pulmonary Drug Delivery Systems Sales by Type (2021-2026) & (M Units)
Table 120. South America Pulmonary Drug Delivery Systems Sales by Application (2016-2021e) & (M Units)
Table 121. South America Pulmonary Drug Delivery Systems Sales by Application (2021-2026) & (M Units)
Table 122. Middle East & Africa Pulmonary Drug Delivery Systems Sales by Country (2016-2021e) & (M Units)
Table 123. Middle East & Africa Pulmonary Drug Delivery Systems Sales by Country (2021-2026) & (M Units)
Table 124. Middle East & Africa Pulmonary Drug Delivery Systems Revenue by Country (2016-2021e) & (USD Million)
Table 125. Middle East & Africa Pulmonary Drug Delivery Systems Revenue by Country (2021-2026) & (USD Million)
Table 126. Middle East & Africa Pulmonary Drug Delivery Systems Sales by Type (2016-2021e) & (M Units)
Table 127. Middle East & Africa Pulmonary Drug Delivery Systems Sales by Type (2021-2026) & (M Units)
Table 128. Middle East & Africa Pulmonary Drug Delivery Systems Sales by Application (2016-2021e) & (M Units)
Table 129. Middle East & Africa Pulmonary Drug Delivery Systems Sales by Application (2021-2026) & (M Units)
Table 130. Direct Channel Pros & Cons
Table 131. Indirect Channel Pros & Cons
Table 132. Pulmonary Drug Delivery Systems Typical Distributors
Table 133. Pulmonary Drug Delivery Systems Typical Customers
List of Figures
Figure 1. Pulmonary Drug Delivery Systems Picture
Figure 2. Global Pulmonary Drug Delivery Systems Sales Market Share by Type in 2020
Figure 3. Nebulizers
Figure 4. Dry Powder Inhaler (DPI)
Figure 5. Metered Dose Inhaler (MDI)
Figure 6. Global Pulmonary Drug Delivery Systems Sales Market Share by Application in 2020
Figure 7. COPD
Figure 8. Asthma
Figure 9. Others
Figure 10. Global Pulmonary Drug Delivery Systems Market Size, (USD Million) & (M Units): 2020 VS 2021 VS 2026
Figure 11. Global Pulmonary Drug Delivery Systems Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. Global Pulmonary Drug Delivery Systems Sales (2016-2026) & (M Units)
Figure 13. Global Pulmonary Drug Delivery Systems Price by Type (2016-2026) & (US$/Unit)
Figure 14. Global Pulmonary Drug Delivery Systems Production Capacity (2016-2026) & (M Units)
Figure 15. Global Pulmonary Drug Delivery Systems Production Capacity by Geographic Region: 2020 VS 2021
Figure 16. Pulmonary Drug Delivery Systems Market Drivers
Figure 17. Pulmonary Drug Delivery Systems Market Restraints
Figure 18. Pulmonary Drug Delivery Systems Market Trends
Figure 19. Global Pulmonary Drug Delivery Systems Sales Market Share by Manufacturer in 2020
Figure 20. Global Pulmonary Drug Delivery Systems Revenue Market Share by Manufacturer in 2020
Figure 21. Pulmonary Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. Top 3 Pulmonary Drug Delivery Systems Manufacturer (Revenue) Market Share in 2020
Figure 23. Top 6 Pulmonary Drug Delivery Systems Manufacturer (Revenue) Market Share in 2020
Figure 24. Global Pulmonary Drug Delivery Systems Sales Market Share by Region (2016-2026)
Figure 25. Global Pulmonary Drug Delivery Systems Revenue Market Share by Region (2016-2026)
Figure 26. North America Pulmonary Drug Delivery Systems Revenue (2016-2026) & (USD Million)
Figure 27. Europe Pulmonary Drug Delivery Systems Revenue (2016-2026) & (USD Million)
Figure 28. Asia-Pacific Pulmonary Drug Delivery Systems Revenue (2016-2026) & (USD Million)
Figure 29. South America Pulmonary Drug Delivery Systems Revenue (2016-2026) & (USD Million)
Figure 30. Middle East & Africa Pulmonary Drug Delivery Systems Revenue (2016-2026) & (USD Million)
Figure 31. Global Pulmonary Drug Delivery Systems Sales Market Share by Type (2016-2026)
Figure 32. Global Pulmonary Drug Delivery Systems Revenue Market Share by Type (2016-2026)
Figure 33. Global Pulmonary Drug Delivery Systems Price by Type (2016-2026) & (US$/Unit)
Figure 34. Global Pulmonary Drug Delivery Systems Sales Market Share by Application (2016-2026)
Figure 35. Global Pulmonary Drug Delivery Systems Revenue Market Share by Application (2016-2026)
Figure 36. Global Pulmonary Drug Delivery Systems Price by Application (2016-2026) & (US$/Unit)
Figure 37. North America Pulmonary Drug Delivery Systems Sales Market Share by Type (2016-2026)
Figure 38. North America Pulmonary Drug Delivery Systems Sales Market Share by Application (2016-2026)
Figure 39. North America Pulmonary Drug Delivery Systems Sales Market Share by Country (2016-2026)
Figure 40. North America Pulmonary Drug Delivery Systems Revenue Market Share by Country (2016-2026)
Figure 41. United States Pulmonary Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Pulmonary Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Pulmonary Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Pulmonary Drug Delivery Systems Sales Market Share by Type (2016-2026)
Figure 45. Europe Pulmonary Drug Delivery Systems Sales Market Share by Application (2016-2026)
Figure 46. Europe Pulmonary Drug Delivery Systems Sales Market Share by Country (2016-2026)
Figure 47. Europe Pulmonary Drug Delivery Systems Revenue Market Share by Country (2016-2026)
Figure 48. Germany Pulmonary Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Pulmonary Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Pulmonary Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Pulmonary Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Pulmonary Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Pulmonary Drug Delivery Systems Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Pulmonary Drug Delivery Systems Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Pulmonary Drug Delivery Systems Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Pulmonary Drug Delivery Systems Revenue Market Share by Region (2016-2026)
Figure 57. China Pulmonary Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Pulmonary Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Korea Pulmonary Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Pulmonary Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Pulmonary Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Pulmonary Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Pulmonary Drug Delivery Systems Sales Market Share by Type (2016-2026)
Figure 64. South America Pulmonary Drug Delivery Systems Sales Market Share by Application (2016-2026)
Figure 65. South America Pulmonary Drug Delivery Systems Sales Market Share by Country (2016-2026)
Figure 66. South America Pulmonary Drug Delivery Systems Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Pulmonary Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Pulmonary Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East & Africa Pulmonary Drug Delivery Systems Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa Pulmonary Drug Delivery Systems Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Pulmonary Drug Delivery Systems Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Pulmonary Drug Delivery Systems Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Pulmonary Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Egypt Pulmonary Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Pulmonary Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Africa Pulmonary Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source

---